Filter
1799
Filtered Results: 1799
Text search:
antigen
Featured
Recommendations
214
New Publications
411
Language
Document type
No document type
857
Guidelines
439
Studies & Reports
209
Manuals
99
Strategic & Response Plan
65
Fact sheets
64
Training Material
18
Situation Updates
18
Brochures
9
Infographics
9
Resource Platforms
5
Online Courses
4
Videos
3
Countries / Regions
India
84
Global
64
Germany
56
Brazil
54
Latin America and the Carribbean
40
Africa
35
Western and Central Europe
34
Kenya
30
Nigeria
30
South Africa
30
Congo, Democratic Republic of
27
Argentina
27
Uganda
24
Sierra Leone
22
Tanzania
22
Paraguay
22
Colombia
21
Nepal
20
Rwanda
20
East and Southern Africa
20
Philippines
19
Zambia
19
Ukraine
18
Malawi
17
Liberia
17
West and Central Africa
16
Ghana
15
Senegal
15
Mozambique
15
Ethiopia
15
Burkina Faso
14
Bangladesh
13
Russia
13
Indonesia
13
Cameroon
12
Zimbabwe
12
Chile
11
Middle East and North Africa
11
Bolivia
11
Peru
10
Namibia
10
Myanmar / Burma
10
El Salvador
9
Venezuela
9
South–East Asia Region
9
Ecuador
8
Syria
7
Eastern Europe and Central Asia
7
Madagascar
7
Lesotho
6
Benin
6
Guinea
6
Haiti
6
Eastern Europe
6
Angola
6
Asia
5
Pakistan
5
Niger
4
USA
4
Cambodia
4
Spain
4
Central African Republic
4
Mali
4
Botswana
4
Somalia
4
Albania
3
Afghanistan
3
Saudi Arabia
3
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Sudan
3
Honduras
3
Libya
3
South Sudan
3
Togo
2
Iran
2
Congo-Brazzaville
2
Guinea-Bissau
2
Jordan
2
Western Pacific Region
2
North America
2
France
2
Portugal
2
Lebanon
2
Djibouti
2
Chad
2
Iraq
2
Eswatini/ Swaziland
2
Guatemala
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
China
1
Kazakhstan
1
Canada
1
Burundi
1
Morocco
1
Qatar
1
Dominican Republic
1
Luxembourg
1
Uruguay
1
Belgium
1
Tunisia
1
United Kingdom
1
Southern Africa
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
752
Clinical Guidelines
245
Pharmacy & Technologies
67
Public Health
66
Women & Child Health
40
Key Resources
28
Capacity Building
16
Toolboxes
COVID-19
359
HIV
155
TB
142
Rapid Response
124
NTDs
113
Ebola
61
Refugee
42
Pharmacy
29
Mental Health
28
Zika
25
Caregiver
23
Polio
18
Conflict
17
AMR
17
NCDs
14
Planetary Health
13
Cholera
10
Natural Hazards
9
Health Financing Toolbox
6
Specific Hazards
5
Global Health Education
5
Disability
1
Social Ethics
1
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured patient training, and monitoring of blood glucose levels. The guidelines emphasize preventing complica...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
Health Statistics in the Western Pacific Region 2023: Monitoring health for the SDGs is the third biennial report providing an overview of the progress of the World Health Organization (WHO) Western Pacific Region towards the health-related Sustainable Development Goal (SDG) targets. Thi...
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
The key to a lasting world free of all forms of poliovirus lies in rapidly interrupting all remaining endemic transmission of WPV in the endemic areas of Pakistan and Afghanistan. This is the only way to ensure that such strains do not re-emerge globally through international spread. It lays the cor...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
The coronavirus outbreak that began in 2019 (COVID-19) threatens to reverse years of hard-won gains in preventing and treating HIV. Fragile health systems are further stressed as health workers navigate an increased client load and demands at work while also being concerned for their own health and ...
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
